Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14NKT cells

被引:42
|
作者
Kamada, N
Iijima, H
Kimura, K
Harada, M
Shimizu, E
Motohashi, S
Kawano, T
Shinkai, H
Nakayama, T
Sakai, T
Brossay, L
Kronenberg, M
Taniguchi, M
机构
[1] Chiba Univ, Grad Sch Med, CREST, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chuo Ku, Chiba 2608670, Japan
[3] Chiba Univ, Sch Med, Dept Dermatol, Chuo Ku, Chiba 2608670, Japan
[4] Kirin Brewery Co Ltd, Pharmaceut Res Lab, Gunma 37012, Japan
[5] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
alpha-galactosylceramide; NKT cell receptor; docking modeling;
D O I
10.1093/intimm/13.7.853
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A novel lymphocyte, NKT cells bearing an invariant V(alpha)14 antigen receptor, specifically recognizes alpha -galactosylceramide (alpha -GalCer) exclusively presented by mouse CD1d (mCD1d). However, the precise molecular interaction remains unclear. For the basis of functional analyses, a docking model of alpha -GalCer with the crystal structure of mCD1d was constructed. Possible residues involved in the alpha -GalCer-mCD1d interaction were found to be Arg79, Glu83 and Asp80 for carbohydrate recognition, and Asp153 for interaction with the amide group on the fatty acyl chain. The alpha -GaLCer-presenting ability of various transfectants expressing mutant mCD1d was completely abrogated it a single amino acid mutation was induced at positions 79, 80, 83 or 153, suggesting that the polar amino acids above the F ' pocket are crucial for alpha -GalCer presentation to activate V alpha 14 NKT cells. The possibility that Glu83 is a contact site for the NKT cell receptor is also discussed.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 50 条
  • [11] MTP activity is required for NKT cell selection and antigen presentation on CD1d
    Dougan, Stephanie K.
    Blumberg, Richard S.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S54 - S54
  • [12] Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand α-galactosylceramide bound to mouse CD1d
    Yu, Karl O. A.
    Im, Jin S.
    Illarionov, Petr A.
    Ndonye, Rachel M.
    Howell, Amy R.
    Besra, Gurdyal S.
    Porcelli, Steven A.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 323 (01) : 11 - 23
  • [13] Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine:: A molecular basis for NKT cell activation
    Giabbai, B
    Sidobre, SP
    Crispin, MDM
    Sanchez-Ruìz, Y
    Bachi, A
    Kronenberg, M
    Wilson, IA
    Degano, M
    JOURNAL OF IMMUNOLOGY, 2005, 175 (02): : 977 - 984
  • [14] Medullublastoma Expresses CD1d and Can Be Targeted for Immunotherapy with NKT Cells
    Song, L.
    Liu, D.
    Metelitsa, L.
    MODERN PATHOLOGY, 2013, 26 : 446A - 447A
  • [15] Medullublastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
    Liu, Daofeng
    Song, Liping
    Brawley, Vita
    Robison, Nathan
    Wei, Jie
    Gao, Xiuhua
    Ahmed, Nabil
    Asgharzadeh, Shahab
    Metelitsa, Leonid
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [16] Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
    Liu, Daofeng
    Song, Liping
    Brawley, Vita S.
    Robison, Nathan
    Wei, Jie
    Gao, Xiuhua
    Tian, Gengwen
    Margol, Ashley
    Ahmed, Nabil
    Asgharzadeh, Shahab
    Metelitsa, Leonid S.
    CLINICAL IMMUNOLOGY, 2013, 149 (01) : 55 - 64
  • [17] CD1d expression and NKT cells in a haploinsufficiency model of NF1
    Liu, Jianyun
    Gallo, Richard
    Khan, Masood
    Renukaradhya, Gourapura
    Brutkiewicz, Randy
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [18] Medullublastoma Expresses CD1d and Can Be Targeted for Immunotherapy with NKT Cells
    Song, L.
    Liu, D.
    Metelitsa, L.
    LABORATORY INVESTIGATION, 2013, 93 : 446A - 447A
  • [19] Presentation of α-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts
    Lang, GA
    Maltsev, SD
    Besra, GS
    Lang, ML
    IMMUNOLOGY, 2004, 112 (03) : 386 - 396
  • [20] Characterization of the ligand binding properties of human CD1d and mouse CD1.
    Maher, JK
    Naidenko, O
    Modlin, R
    Kronenberg, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 52 - 52